Skip to main content
Cenra Inc. logo

Cenra Inc. — Investor Relations & Filings

Ticker · 3716 ISIN · TW0003716007 TW Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2025-10-09 Transaction in Own Shar…
Country TW Taiwan
Listing TW 3716

About Cenra Inc.

https://www.cenra.com/

Cenra Inc. is a diversified healthcare enterprise with a history dating back to 1952. The company operates across a comprehensive value chain encompassing research and development, manufacturing, commercial marketing, and long-term care services. Its extensive portfolio includes active pharmaceutical ingredients (APIs), human pharmaceuticals, animal health products, and consumer health brands such as dietary supplements and personal care items. With a global reach spanning over 60 markets, the organization utilizes nine production bases and more than ten specialized technology platforms to deliver integrated health solutions. Cenra Inc. focuses on high-barrier oncology medications, complex generics, and 505(b)(2) drug developments. By integrating scientific innovation with rigorous operational management, the company provides accessible medical care and health services designed to meet evolving needs across all life stages.

Recent filings

Filing Released Lang Actions
公告本公司第3次買回庫藏股期間屆滿及執行情形
Transaction in Own Shares Classification · 100% confidence The document is a company announcement regarding the completion and execution details of a share buyback program (treasury stock repurchase). It includes specific data such as the number of shares repurchased, price range, total amount spent, and reasons for partial execution. The content is focused on the transaction of the company's own shares and does not contain financial statements or broader financial results. The document length is short (822 characters) and it is a factual update on share repurchase activity, which fits the category of Transaction in Own Shares (POS).
2025-10-09 Chinese
114年10月僑外投資持股
Major Shareholding Notification Classification · 95% confidence The document is a statistical table showing the shareholding situation of overseas and mainland China investors, including changes before and after a shareholders' meeting date. It includes details on share counts and categories but does not contain financial statements, management discussion, or report narratives. The document length is short (1071 characters) and it is a regulatory disclosure of shareholding information related to a shareholders' meeting. This fits best with a Major Shareholding Notification (MRQ) as it reports on share ownership levels and changes, especially for foreign investors, rather than a full financial report or announcement of voting results. It is not a report publication announcement or certification. Therefore, the classification is MRQ with high confidence.
2025-10-08 Chinese
公告本公司名稱由「中化投資控股股份有限公司」 更名為「中化控股股份有限公司」， 公告期間：114年07月09日至114年10月08日
Regulatory Filings Classification · 95% confidence The document is a short announcement (898 characters) about a company name change from "中化投資控股股份有限公司" to "中化控股股份有限公司". It includes details such as the approval date, shareholder meeting resolution date, and regulatory approval number. There is no financial data, no report attached or referenced, and no indication of a meeting or voting results beyond the name change approval. The document is a regulatory announcement about a corporate action (name change) rather than a financial report or detailed management information. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-10-08 Chinese
114年09月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, managers, and other key personnel, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider share ownership and transactions, which is typical of a Director's Dealing report. There is no indication of financial statements, earnings data, or meeting materials. The document length is about 9608 characters, which is sufficient for a detailed insider shareholding report. Therefore, the document is best classified as a Director's Dealing report.
2025-10-07 Chinese
114年09月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by company insiders, including directors, managers, and major shareholders. It lists current and initial shareholdings, pledged shares, and related percentages. The content focuses on insider shareholdings and pledges rather than financial results, management changes, or meeting materials. This type of document corresponds to a Director's Dealing report, which discloses personal share transactions or holdings by company directors and executives. The document length is 2627 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report. Therefore, the appropriate classification is Director's Dealing (DIRS).
2025-10-07 Chinese
公告本公司名稱由「中化投資控股股份有限公司」 更名為「中化控股股份有限公司」， 公告期間：114年07月09日至114年10月08日
Regulatory Filings Classification · 100% confidence The document is a short announcement (898 characters) about a company name change from '中化投資控股股份有限公司' to '中化控股股份有限公司'. It includes details such as approval dates, shareholder meeting resolution date, and regulatory approval number. There is no financial data, no report attached or referenced as being published, and no mention of financial results or management changes beyond the name change. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about a corporate name change and does not fit into more specific categories like Annual Report, Management Information, or Capital Update.
2025-10-07 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.